Alfucare Tablet 10mg (Alfuzosin Hydrochloride)

Adult dose

The recommended dose is 10mg once daily, taken immediately after the evening meal. Swallow the tablet whole at once; do not chew it. When administered as adjunctive therapy to catheterization for acute urinary retention associated with benign prostatic hyperplasia, the recommended dose is 10mg once daily, taken after a meal starting on the first day of catheterization. Take it for 2-3 days while the catheter is in place and for 1 day after catheter removal, for a total of 3-4 days.

This medication is an alpha-1 blocker primarily used in the treatment of conditions such as benign prostatic hyperplasia. This medication should not be used in individuals allergic to alfuzosin or any other ingredients in the medication, patients with orthostatic hypotension, those with severely impaired liver function, severely reduced kidney function, bowel obstruction, patients already on other alpha blockers, or those taking strong CYP3A4 inhibitors. Additionally, this drug can cause orthostatic hypotension when first administered, especially in patients taking other antihypertensive medications. Symptoms such as dizziness, fatigue, and sweating may occur; if these symptoms arise, it is advisable to rest lying down. Older adults and those with heart conditions should be more cautious, and if symptoms are severe, medical consultation is necessary. This medication should not be used alone in patients with coronary artery diseases, and should be discontinued if angina symptoms worsen. It should also be administered cautiously in patients with prolonged QT interval or those taking QT-prolonging medications. Common side effects include dizziness, headache, fainting, upper respiratory infections, dyspepsia, constipation, fatigue, and erectile dysfunction. If these symptoms occur, inform your doctor. Rarely, skin rash or thrombocytopenia has been reported. Patients planning cataract surgery should inform their ophthalmologist of this medication usage, and the tablets should be swallowed whole, not crushed or chewed. Moreover, taking it in conjunction with other alpha blockers or strong CYP3A4 inhibitors may increase the risk of side effects such as hypotension, so caution is needed. This medication is not suitable for pregnant or breastfeeding women or pediatric patients. During the initial use of this medication, dizziness or fatigue may occur, requiring caution when driving or operating machinery. In case of overdose, appropriate treatment should be sought immediately, as this medication is not easily removed by dialysis. Finally, this medication should be stored out of reach of children and should not be transferred to another container for safety.

• fainting
• dizziness
• headache
• vertigo
• syncope
• tachycardia
• angina
• atrial fibrillation
• intraoperative floppy iris syndrome
• upper respiratory tract infection

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance

This medication is a round, film-coated tablet composed of three layers: one white layer inserted between two yellow layers, with both sides being convex.

Package unit

30 tablets (bottle), 100 tablets (bottle)